Advertisement Velos Releases Software To Support Cancer Centers With New Workflow, Content - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Velos Releases Software To Support Cancer Centers With New Workflow, Content

Software to support NCI clinical trials reporting program

Velos has released a software to support cancer centers with new workflow and content for the US National Cancer Institute (NCI) Clinical Trials Reporting Program (CTRP).

The company said that it has proactively developed these capabilities and functions to ease and streamline registration of interventional trials. The content, based on specifications published for the CTRP, delivers capabilities for customers to create outputs that can be uploaded to the NCI in specified formats.

Moreover, customers who would otherwise be burdened by multiple manual, software, and email reporting processes now have a streamlined, single system with one data source, resulting in multiple CTRP-ready outputs.

Priti Sahai, vice president for Product Development, Velos, said: “We at Velos are consistently watchful and alert to all indicators from the NCI regarding new programs to which our cancer center community will need to respond.”

These registration requirements are important to the NCI and to the industry as a whole because they are an essential, information-gathering initiative. Through this program, the NCI can carry out a prioritization process to more effectively focus resources on trials judged most likely to facilitate advances in treatment. However, they are not without complexity, and they impose a significant new workload on the cancer care and research community. Our effort with this new release of capabilities is to minimize effort and maximize automation in support of the new trial reporting requirements. he added.